Why the study?
CKD poses a significant global health challenge due to elevated cardiovascular risks, prompting exploration of the multifaceted role of statins beyond traditional lipid-lowering functions.
Do statins improve cardiovascular and renal outcomes in patients with chronic kidney disease?
Do statins improve cardiovascular and renal outcomes in patients with chronic kidney disease?
Statins play a crucial, multifaceted role in managing cardiovascular and renal risks in CKD, necessitating personalized clinical application.
May inform personalized statin use in CKD; leaves open confirmation of consistent outcome benefits in prospective trials.
This comprehensive review examines the multifaceted role of statins in managing chronic kidney disease (CKD), highlighting their impact beyond traditional lipid-lowering functions. CKD poses a significant global health challenge due to its association with elevated cardiovascular risks. Statins, known primarily for lowering cholesterol, have been explored for their potential benefits in both cardiovascular and renal aspects of CKD. This review discusses statins’ mechanisms of action, including lipid-lowering effects, anti-inflammatory properties, and potential reno-protective mechanisms. By evaluating evidence from clinical studies, it addresses the impact of statins on cardiovascular outcomes, atherosclerosis reduction, and renal function, specifically in terms of proteinuria and glomerular filtration rate. Addressing safety concerns, it also delves into common side effects, monitoring strategies, and considerations for CKD patients. Challenges and controversies surrounding statin therapy, such as individual variability, applicability across CKD stages, and long-term effects, are thoroughly examined. The implications for clinical practice underscore the need for a personalized approach, while the conclusion emphasizes the evolving role of statins as crucial components in the comprehensive management of CKD, highlighting potential benefits and challenges in this complex landscape.
No takes yet. Share an insight, caveat, or question.
Toshniwal et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: